| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.67e-10 | 37 | 104 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.36e-10 | 38 | 104 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.57e-09 | 11 | 104 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.71e-09 | 14 | 104 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.62e-08 | 21 | 104 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.33e-06 | 37 | 104 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.52e-06 | 38 | 104 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.02e-06 | 46 | 104 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 USP34 RHBDF1 RHBDF2 CELA2A ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 | 1.50e-05 | 430 | 104 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.77e-05 | 79 | 104 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity | 8.03e-05 | 3 | 104 | 2 | GO:0015018 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.45e-04 | 152 | 104 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.47e-04 | 20 | 104 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 USP34 RHBDF1 RHBDF2 CELA2A ERVK-7 ERVK-10 USP42 ERVK-8 ERVK-18 ERVK-19 ERVK-25 | 1.52e-04 | 654 | 104 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 1.60e-04 | 4 | 104 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.66e-04 | 5 | 104 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | IgE receptor activity | 3.98e-04 | 6 | 104 | 2 | GO:0019767 | |
| GeneOntologyMolecularFunction | IgE binding | 5.55e-04 | 7 | 104 | 2 | GO:0019863 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 5.55e-04 | 7 | 104 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.30e-04 | 136 | 104 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 7.30e-04 | 136 | 104 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 8.65e-04 | 36 | 104 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.33e-03 | 231 | 104 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | IgG binding | 1.43e-03 | 11 | 104 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.52e-03 | 417 | 104 | 8 | GO:0140098 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.73e-03 | 165 | 104 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.00e-03 | 102 | 104 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.12e-03 | 49 | 104 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.25e-03 | 50 | 104 | 3 | GO:0003755 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 2.35e-03 | 14 | 104 | 2 | GO:0019763 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.50e-03 | 262 | 104 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.66e-03 | 53 | 104 | 3 | GO:0016859 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 3.07e-03 | 16 | 104 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | cholesterol binding | 3.44e-03 | 58 | 104 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | actin binding | 3.57e-03 | 479 | 104 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 4.80e-03 | 20 | 104 | 2 | GO:0016638 | |
| GeneOntologyMolecularFunction | lipid binding | FNBP1 CPNE8 CPNE9 SPTBN1 CRABP1 CLEC4F FCGR3A FCGR3B OSBPL7 OSBPL6 OSBPL10 MCOLN3 | 5.28e-03 | 988 | 104 | 12 | GO:0008289 |
| GeneOntologyBiologicalProcess | DNA integration | 3.34e-09 | 13 | 102 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.57e-06 | 20 | 102 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.87e-06 | 48 | 102 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 9.65e-06 | 9 | 102 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.37e-05 | 10 | 102 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | perforin production | 2.42e-05 | 2 | 102 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 3.24e-05 | 13 | 102 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 4.11e-05 | 14 | 102 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 5.73e-05 | 83 | 102 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.58e-04 | 178 | 102 | 6 | GO:0006261 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.58e-06 | 8 | 104 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.40e-05 | 10 | 104 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.18e-05 | 14 | 104 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 9.25e-05 | 18 | 104 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.28e-04 | 20 | 104 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 1.46e-04 | 4 | 104 | 2 | GO:0033001 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.49e-04 | 21 | 104 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 3.98e-04 | 29 | 104 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.31e-03 | 11 | 104 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.31e-03 | 11 | 104 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.31e-03 | 11 | 104 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.31e-03 | 11 | 104 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | Fc receptor complex | 1.57e-03 | 12 | 104 | 2 | GO:0032997 | |
| GeneOntologyCellularComponent | nuclear pore | 1.63e-03 | 101 | 104 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.81e-03 | 349 | 104 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear envelope | 1.92e-03 | 560 | 104 | 9 | GO:0005635 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RHBDF1 RGPD8 RHBDF2 SYNE1 RGPD1 KSR1 DST ARL6IP1 PGAP2 RGPD3 SYNE2 OSBPL7 OSBPL6 B3GAT1 PHTF1 | 2.33e-03 | 1327 | 104 | 15 | GO:0042175 |
| Domain | Actinin_actin-bd_CS | 9.58e-08 | 23 | 95 | 5 | IPR001589 | |
| Domain | ACTININ_2 | 9.58e-08 | 23 | 95 | 5 | PS00020 | |
| Domain | ACTININ_1 | 9.58e-08 | 23 | 95 | 5 | PS00019 | |
| Domain | Grip | 2.02e-07 | 11 | 95 | 4 | SM00755 | |
| Domain | GRIP | 2.02e-07 | 11 | 95 | 4 | PF01465 | |
| Domain | Ran_BP1 | 3.01e-07 | 12 | 95 | 4 | PF00638 | |
| Domain | GRIP_dom | 3.01e-07 | 12 | 95 | 4 | IPR000237 | |
| Domain | GRIP | 3.01e-07 | 12 | 95 | 4 | PS50913 | |
| Domain | RANBD1 | 3.01e-07 | 12 | 95 | 4 | PS50196 | |
| Domain | RanBD | 4.34e-07 | 13 | 95 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 4.34e-07 | 13 | 95 | 4 | IPR000156 | |
| Domain | GCC2_Rab_bind | 4.40e-06 | 7 | 95 | 3 | IPR032023 | |
| Domain | Rab_bind | 4.40e-06 | 7 | 95 | 3 | PF16704 | |
| Domain | Spectrin | 5.16e-06 | 23 | 95 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 1.35e-05 | 29 | 95 | 4 | IPR002017 | |
| Domain | - | 1.49e-05 | 10 | 95 | 3 | 1.10.220.60 | |
| Domain | CH | 1.99e-05 | 65 | 95 | 5 | SM00033 | |
| Domain | Spectrin/alpha-actinin | 2.03e-05 | 32 | 95 | 4 | IPR018159 | |
| Domain | SPEC | 2.03e-05 | 32 | 95 | 4 | SM00150 | |
| Domain | Rhomboid_SP | 2.56e-05 | 2 | 95 | 2 | IPR022241 | |
| Domain | Rhomboid_SP | 2.56e-05 | 2 | 95 | 2 | PF12595 | |
| Domain | Oxysterol-bd | 2.71e-05 | 12 | 95 | 3 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 2.71e-05 | 12 | 95 | 3 | IPR018494 | |
| Domain | Oxysterol_BP | 2.71e-05 | 12 | 95 | 3 | PF01237 | |
| Domain | OSBP | 2.71e-05 | 12 | 95 | 3 | PS01013 | |
| Domain | CH | 2.85e-05 | 70 | 95 | 5 | PF00307 | |
| Domain | - | 3.06e-05 | 71 | 95 | 5 | 1.10.418.10 | |
| Domain | CH | 3.50e-05 | 73 | 95 | 5 | PS50021 | |
| Domain | CH-domain | 3.99e-05 | 75 | 95 | 5 | IPR001715 | |
| Domain | Glyco_trans_43 | 7.65e-05 | 3 | 95 | 2 | IPR005027 | |
| Domain | Glyco_transf_43 | 7.65e-05 | 3 | 95 | 2 | PF03360 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | PF10541 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | IPR012315 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | PS51049 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | SM01249 | |
| Domain | Peptidase_S54_rhomboid | 7.03e-04 | 8 | 95 | 2 | IPR002610 | |
| Domain | Copine | 9.00e-04 | 9 | 95 | 2 | PF07002 | |
| Domain | Rhomboid | 9.00e-04 | 9 | 95 | 2 | PF01694 | |
| Domain | Peptidase_S54_rhomboid_dom | 9.00e-04 | 9 | 95 | 2 | IPR022764 | |
| Domain | Copine | 9.00e-04 | 9 | 95 | 2 | IPR010734 | |
| Domain | - | 9.00e-04 | 9 | 95 | 2 | 1.20.1540.10 | |
| Domain | PH_dom-like | 1.48e-03 | 426 | 95 | 8 | IPR011993 | |
| Domain | WD_REPEATS_1 | 2.96e-03 | 278 | 95 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.02e-03 | 279 | 95 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.02e-03 | 279 | 95 | 6 | PS50294 | |
| Domain | - | 3.81e-03 | 391 | 95 | 7 | 2.30.29.30 | |
| Domain | WD40_repeat_dom | 4.09e-03 | 297 | 95 | 6 | IPR017986 | |
| Domain | Ig_2 | 6.13e-03 | 73 | 95 | 3 | PF13895 | |
| Domain | TPR-like_helical_dom | 6.76e-03 | 233 | 95 | 5 | IPR011990 | |
| Domain | - | 7.08e-03 | 333 | 95 | 6 | 2.130.10.10 | |
| Domain | TPR-contain_dom | 7.23e-03 | 150 | 95 | 4 | IPR013026 | |
| Domain | WD40/YVTN_repeat-like_dom | 7.28e-03 | 335 | 95 | 6 | IPR015943 | |
| Domain | C2_dom | 9.83e-03 | 164 | 95 | 4 | IPR000008 | |
| Domain | TPR_REGION | 1.00e-02 | 165 | 95 | 4 | PS50293 | |
| Domain | TPR | 1.00e-02 | 165 | 95 | 4 | PS50005 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.53e-06 | 18 | 69 | 4 | MM1549 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.62e-05 | 43 | 69 | 4 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.02e-04 | 50 | 69 | 4 | MM14610 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.91e-10 | 5 | 105 | 4 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-11 | 4.73e-10 | 94 | 105 | 8 | 21542922 |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.73e-09 | 7 | 105 | 4 | 15710750 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 10516026 | ||
| Pubmed | 7.10e-08 | 332 | 105 | 10 | 25693804 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.07e-07 | 4 | 105 | 3 | 10469592 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 7983737 | ||
| Pubmed | 2.32e-07 | 18 | 105 | 4 | 18664271 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 21205196 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 18949001 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 25187515 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 9037092 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 8603673 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 26632511 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 24403063 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 9.28e-07 | 7 | 105 | 3 | 11353387 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 30944974 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 38838144 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 9.28e-07 | 7 | 105 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 9.28e-07 | 7 | 105 | 3 | 17372272 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 38657106 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 12191015 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 22821000 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.48e-06 | 8 | 105 | 3 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.48e-06 | 8 | 105 | 3 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.48e-06 | 8 | 105 | 3 | 28745977 | |
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.48e-06 | 8 | 105 | 3 | 21310149 | |
| Pubmed | FLNB MYLK RGPD8 SYNE1 SPTBN1 BIVM RGPD1 NCBP1 CHUK DST UMODL1 PAEP RGPD3 SYNE2 SMURF2 PHTF1 RGPD5 | 1.49e-06 | 1442 | 105 | 17 | 35575683 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.22e-06 | 9 | 105 | 3 | 18394993 | |
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 11553612 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 10601307 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 9733766 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 28100513 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 28877029 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 3.16e-06 | 10 | 105 | 3 | 8857542 | |
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.16e-06 | 10 | 105 | 3 | 16332688 | |
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 4.33e-06 | 11 | 105 | 3 | 35771867 | |
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 11483621 | ||
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 17069463 | ||
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 34110283 | ||
| Pubmed | USP34 FLNB SPTBN1 WDR18 NCBP1 TRRAP DST GLYR1 SYNE2 PYGB PHIP | 4.75e-06 | 653 | 105 | 11 | 22586326 | |
| Pubmed | The first avian Ig-like Fc receptor family member combines features of mammalian FcR and FCRL. | 5.77e-06 | 12 | 105 | 3 | 17273841 | |
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 5.77e-06 | 12 | 105 | 3 | 11735225 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 5.77e-06 | 12 | 105 | 3 | 12215260 | |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 14557543 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 7.48e-06 | 13 | 105 | 3 | 31427429 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22768332 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2521732 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 34108956 | ||
| Pubmed | Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers. | 9.03e-06 | 2 | 105 | 2 | 33163982 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35585977 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11792814 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23770975 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 9.03e-06 | 2 | 105 | 2 | 24931616 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26494566 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23969955 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22290871 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20980704 | ||
| Pubmed | Nucleotide sequence of a new Fc gamma receptor IIIB allele that codes for a neutrophil antigen. | 9.03e-06 | 2 | 105 | 2 | 11034564 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19461047 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9060628 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23917248 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 9.03e-06 | 2 | 105 | 2 | 9460924 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19320901 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 9.03e-06 | 2 | 105 | 2 | 17267447 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32646486 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25966632 | ||
| Pubmed | The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. | 9.03e-06 | 2 | 105 | 2 | 2967436 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 9.03e-06 | 2 | 105 | 2 | 24718612 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8940055 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24586179 | ||
| Pubmed | FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis. | 9.03e-06 | 2 | 105 | 2 | 27059607 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24387768 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17761684 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31578382 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17935701 | ||
| Pubmed | Low copy numbers of FCGR3A and FCGR3B associated with Chinese patients with SLE and AASV. | 9.03e-06 | 2 | 105 | 2 | 28355982 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31661139 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25154742 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7836402 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25816339 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2525780 | ||
| Pubmed | FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma. | 9.03e-06 | 2 | 105 | 2 | 12445195 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2526846 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26659409 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 9.03e-06 | 2 | 105 | 2 | 11672541 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20664961 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18292508 | ||
| Pubmed | 1.18e-05 | 15 | 105 | 3 | 14697343 | ||
| Pubmed | 2.11e-05 | 18 | 105 | 3 | 27001747 | ||
| Pubmed | 2.31e-05 | 187 | 105 | 6 | 26460568 | ||
| Pubmed | Association of Fcgamma receptor IIa genotype with chronic periodontitis in Caucasians. | 2.70e-05 | 3 | 105 | 2 | 15152814 | |
| Pubmed | Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. | 2.70e-05 | 3 | 105 | 2 | 25775045 | |
| Interaction | RGPD4 interactions | 3.90e-06 | 22 | 100 | 4 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 9.17e-06 | 27 | 100 | 4 | int:RGPD2 | |
| Interaction | HSPB8 interactions | 2.40e-05 | 172 | 100 | 7 | int:HSPB8 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.19e-05 | 12 | 70 | 3 | 670 | |
| GeneFamily | Beta-1,3-glucuronyltransferases | 4.42e-05 | 3 | 70 | 2 | 423 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 8.82e-05 | 4 | 70 | 2 | 1252 | |
| GeneFamily | Copines | 5.23e-04 | 9 | 70 | 2 | 829 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.03e-03 | 115 | 70 | 4 | 769 | |
| GeneFamily | Rhomboid family | 1.30e-03 | 14 | 70 | 2 | 926 | |
| GeneFamily | WD repeat domain containing | 3.46e-03 | 262 | 70 | 5 | 362 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.18e-03 | 394 | 70 | 6 | 471 | |
| GeneFamily | Immunoglobulin like domain containing | 6.67e-03 | 193 | 70 | 4 | 594 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-07 | 199 | 97 | 7 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-07 | 199 | 97 | 7 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-06 | 160 | 97 | 6 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-06 | 160 | 97 | 6 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 3.13e-06 | 184 | 97 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 187 | 97 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.65e-06 | 189 | 97 | 6 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.76e-06 | 190 | 97 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.12e-06 | 193 | 97 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 194 | 97 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.37e-06 | 195 | 97 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.37e-06 | 195 | 97 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.37e-06 | 195 | 97 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-06 | 196 | 97 | 6 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-06 | 196 | 97 | 6 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.77e-06 | 198 | 97 | 6 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-06 | 198 | 97 | 6 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.77e-06 | 198 | 97 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.77e-06 | 198 | 97 | 6 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-06 | 198 | 97 | 6 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-06 | 198 | 97 | 6 | e76061e66f6d60f5735962aa7777dda8958caed9 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.77e-06 | 198 | 97 | 6 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.91e-06 | 199 | 97 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.91e-06 | 199 | 97 | 6 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.91e-06 | 199 | 97 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.91e-06 | 199 | 97 | 6 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.91e-06 | 199 | 97 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-06 | 199 | 97 | 6 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-06 | 199 | 97 | 6 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.91e-06 | 199 | 97 | 6 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.91e-06 | 199 | 97 | 6 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.91e-06 | 199 | 97 | 6 | 5e9fe852a70546c9d235414a2c26ca3e67ba6eb9 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 4.91e-06 | 199 | 97 | 6 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.91e-06 | 199 | 97 | 6 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.91e-06 | 199 | 97 | 6 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.91e-06 | 199 | 97 | 6 | d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 5.05e-06 | 200 | 97 | 6 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.05e-06 | 200 | 97 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.88e-05 | 149 | 97 | 5 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.88e-05 | 149 | 97 | 5 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Immune_cells-Neutrophils|World / Lineage and Cell class | 2.00e-05 | 151 | 97 | 5 | 056301bedb4285e797250b55d79ee1790a17516d | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-05 | 159 | 97 | 5 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 165 | 97 | 5 | be7e18d798e81e4b0f3080054aa222c6913e350b | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 165 | 97 | 5 | 941a5b95164eaea47c3e6376e358f94c15b98312 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 3.44e-05 | 169 | 97 | 5 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.53e-05 | 170 | 97 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 174 | 97 | 5 | dc4298c1d9359f7e37454e9451f889017227d5cf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 175 | 97 | 5 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-05 | 176 | 97 | 5 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 4.17e-05 | 176 | 97 | 5 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-05 | 176 | 97 | 5 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-05 | 177 | 97 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-05 | 177 | 97 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.28e-05 | 177 | 97 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.28e-05 | 177 | 97 | 5 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-05 | 177 | 97 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.28e-05 | 177 | 97 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 178 | 97 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.52e-05 | 179 | 97 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 4.64e-05 | 180 | 97 | 5 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.64e-05 | 180 | 97 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 5.02e-05 | 183 | 97 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 185 | 97 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-05 | 186 | 97 | 5 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.42e-05 | 186 | 97 | 5 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.70e-05 | 188 | 97 | 5 | 48dcbb424771a2f839d65b0c429ef01ad3479a4a | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.70e-05 | 188 | 97 | 5 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 189 | 97 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-05 | 190 | 97 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.99e-05 | 190 | 97 | 5 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.99e-05 | 190 | 97 | 5 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 191 | 97 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 191 | 97 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 191 | 97 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 192 | 97 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.30e-05 | 192 | 97 | 5 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-05 | 193 | 97 | 5 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 193 | 97 | 5 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 193 | 97 | 5 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.46e-05 | 193 | 97 | 5 | c1d9c2436503791350086a503d6b98c5c69f44ae | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-05 | 193 | 97 | 5 | db26b79dfe9c48388f6b64dceb21073d104ab504 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-05 | 194 | 97 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 194 | 97 | 5 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.61e-05 | 194 | 97 | 5 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 194 | 97 | 5 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.61e-05 | 194 | 97 | 5 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| Drug | Fnllp | 3.26e-07 | 14 | 99 | 4 | CID000119508 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 9.83e-06 | 2 | 93 | 2 | OBA_2040305 | |
| Disease | Lupus Vasculitis, Central Nervous System | 2.94e-05 | 3 | 93 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 2.94e-05 | 3 | 93 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 2.94e-05 | 3 | 93 | 2 | C0752335 | |
| Disease | FEV/FEC ratio | USP34 RNLS FPR1 C1GALT1 CRABP1 DST FCGR3A FCGR3B SYNE2 AEBP2 KCNMB1 CSMD1 CCDC171 SMURF2 | 2.99e-05 | 1228 | 93 | 14 | EFO_0004713 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 5.87e-05 | 4 | 93 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 9.77e-05 | 5 | 93 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 9.77e-05 | 5 | 93 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.46e-04 | 6 | 93 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.46e-04 | 6 | 93 | 2 | C0410189 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 2.04e-04 | 7 | 93 | 2 | EFO_0008211 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.04e-04 | 7 | 93 | 2 | C0751337 | |
| Disease | plexin-B2 measurement | 3.49e-04 | 9 | 93 | 2 | EFO_0021867 | |
| Disease | response to carboplatin, response to antineoplastic agent | 4.35e-04 | 10 | 93 | 2 | GO_0097327, GO_0097328 | |
| Disease | aspartate aminotransferase measurement | MAGI1 FLNB RNF213 C1GALT1 FCGR3A FCGR3B OSBPL6 CSMD1 LY75 PHIP | 5.64e-04 | 904 | 93 | 10 | EFO_0004736 |
| Disease | monokine induced by gamma interferon measurement | 5.99e-04 | 52 | 93 | 3 | EFO_0008236 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 6.35e-04 | 12 | 93 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0008212 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 9.11e-04 | 60 | 93 | 3 | C4722327 | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.15e-03 | 16 | 93 | 2 | C3203102 | |
| Disease | interstitial lung disease | 1.25e-03 | 67 | 93 | 3 | EFO_0004244 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 1.30e-03 | 17 | 93 | 2 | EFO_0021969 | |
| Disease | serum IgG glycosylation measurement | 1.35e-03 | 523 | 93 | 7 | EFO_0005193 | |
| Disease | Prostate cancer, familial | 1.37e-03 | 69 | 93 | 3 | C2931456 | |
| Disease | bipolar disorder | 2.35e-03 | 577 | 93 | 7 | MONDO_0004985 | |
| Disease | cortical thickness | MAGI1 FLNB RNLS SPTBN1 C1GALT1 AP3M1 UMODL1 GLYR1 PYGB CCDC171 | 2.66e-03 | 1113 | 93 | 10 | EFO_0004840 |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0021970 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKSNLKVVLTECWAT | 1146 | Q5DID0 | |
| AANCTKILVWHTRTE | 301 | Q9P2W7 | |
| RTVNLKSATWKVLHC | 181 | Q99814 | |
| WVNESERHQLKTKVV | 461 | Q6ZN18 | |
| SVRICLQDHKWSGQT | 2716 | Q96PZ7 | |
| WVLKHCERFLKQQQT | 1036 | Q96NH3 | |
| RHLWKIISEEVQNKC | 2426 | Q86UK0 | |
| ISCHAWNKDRTQIAI | 11 | O15143 | |
| EQIKAQESCWHRQKK | 651 | Q6TFL3 | |
| KTRNARAQCVGWHSK | 341 | Q8IZF3 | |
| HVRKSVNAELCTQAW | 101 | Q8IYT2 | |
| HCKKWADIVTDLNTQ | 371 | Q86UB2 | |
| KWTTEQQQRFHEICS | 96 | Q15041 | |
| SVSKIVVHKDWNSNQ | 101 | P08217 | |
| LEKHWKSVVSQSVCD | 16 | Q9Y2T2 | |
| VSQLCEDKHSQCKWV | 111 | Q8WXS4 | |
| KCRSLATWENENKIH | 81 | P29762 | |
| REQVLKVCANHWITT | 1101 | Q99666 | |
| REQVLKVCANHWITT | 1101 | O14715 | |
| SVENVWTTCRANKQK | 716 | Q4ADV7 | |
| VWTQESKCHLIETNI | 46 | Q16558 | |
| LHRWENNSCVEKKVL | 76 | P09466 | |
| CILWRLTKKHTVSQE | 161 | Q9UHJ9 | |
| TLRKNVAVNCSTEWK | 356 | A0AUZ9 | |
| TRLIQKLHTSTCWLQ | 71 | Q2VYF4 | |
| QVSCSAWVTVHEKKS | 591 | Q15746 | |
| LFQTIHKTIKDCKWQ | 116 | Q3MHD2 | |
| QKKNHWTSRVHECTV | 6 | Q96QZ7 | |
| QWHCGVRVSSNKKLV | 211 | O60551 | |
| IIKSHWKERKTCAAQ | 321 | Q09161 | |
| IRECKDWHVSGSIQK | 266 | Q8TDD5 | |
| RHVKDKVVQTNCKNW | 346 | Q8IYA8 | |
| CVLANNSHRAKWKVI | 911 | Q03001 | |
| RQKEIWHLLKIACTQ | 646 | O15111 | |
| QNHCRSEVILEKWQK | 356 | Q9NRM6 | |
| QICDKHWTAKNSRVV | 216 | Q9Y4K0 | |
| TFTRWCNEHLKCVNK | 21 | O75369 | |
| QTWHPCLTKFTIKNQ | 196 | Q9NRY7 | |
| STKSWLSQVCHVCQK | 351 | Q8IVT5 | |
| HTVTVWNRTAEKCDL | 291 | Q49A26 | |
| DVTWKQAKDIVQHCT | 611 | P63132 | |
| TLTWHSAKRECLKSN | 1121 | O60449 | |
| VEEKESWKKTCTTQH | 2206 | Q8NG31 | |
| CSVWISNKTAKQHSL | 656 | Q9BSJ2 | |
| WNKVTTCIHNILSGR | 726 | Q9BZF3 | |
| DVTWKQAKDIVQHCT | 611 | P63135 | |
| DVTWKQAKDIVQHCT | 611 | Q9BXR3 | |
| IVSWKKSHLRTVEHC | 81 | Q15546 | |
| LKWKDKTRHVLQCQA | 411 | P32942 | |
| VKQVWDSVCVKSVHT | 731 | Q460N5 | |
| DVTWKQAKDIVQHCT | 611 | Q9QC07 | |
| QREQVLKVCANHWIT | 1101 | A6NKT7 | |
| QKLKSWEFQTCHSTV | 561 | Q8N8U9 | |
| QSKCWQRVTRKCHED | 241 | Q6UXV0 | |
| RKAQQHIETCWKQLE | 121 | Q96RU3 | |
| NNCTKVLVWHTRTEK | 291 | Q9NPZ5 | |
| CHKTEVVKNTLNPVW | 186 | Q8IYJ1 | |
| SLKWTQAVHCARNIV | 56 | O60756 | |
| RQKTWHKITDTCQTL | 136 | Q8IZF7 | |
| LRCHSWKNTALHKVT | 126 | O75015 | |
| HVKATWAQRCNKVLF | 106 | Q9NS00 | |
| TNKITSVHSRIIWSC | 661 | Q6IA86 | |
| WCKAETVTHRIRKQS | 176 | Q96LA5 | |
| TLEKVIEIQSKHWSC | 1046 | Q9UQL6 | |
| IEIQSKHWSCVQKFA | 1051 | Q9UQL6 | |
| LRCHSWKNTALHKVT | 126 | P08637 | |
| VHNKAVIWQKSRVSD | 191 | P54277 | |
| CHKTEVVKNTLNPVW | 196 | Q86YQ8 | |
| QVELKTRKTCFWRHQ | 226 | Q8N5C7 | |
| DCVIHWINSNKTNIR | 376 | Q6UXK5 | |
| KVTSCIHNVLSGQRW | 636 | Q9BZF2 | |
| RDQVLKVCANHWITT | 1086 | P0DJD0 | |
| VTNCQERIQHWKKVD | 41 | O94763 | |
| EIVQKRTFTKWINSH | 26 | Q8NF91 | |
| EEKCQNTHKRWTQVN | 5356 | Q8WXH0 | |
| VWTQNHRTVSLAKKV | 131 | P21462 | |
| DSTQKWQRKSIRHCS | 96 | Q96CC6 | |
| WDVQSKQCIRTVALK | 296 | Q9BV38 | |
| CEEKRLCVNTHVWTK | 546 | Q9BXB5 | |
| HLECNETKSWIREKT | 961 | Q01082 | |
| ILTASRQSHVWEQKV | 466 | Q8TE77 | |
| KTQKISSCVLRWDNE | 201 | Q7Z624 | |
| VKKSWHEAEQFCVSQ | 486 | Q8N1N0 | |
| TWKLAKDIVQHCTQC | 611 | P63136 | |
| TRLKHCTPDSNIVKW | 641 | Q9HAU4 | |
| HCSKIWSCRKRITVE | 4736 | Q63HN8 | |
| SEKICLKWQQTHRVG | 96 | Q9H9J4 | |
| VCWKAFSQKSQLIIH | 546 | P17025 | |
| QSLLRTNKSCKHVVW | 106 | Q8WWQ0 | |
| LNSQVKKTTTRWCHI | 316 | Q9UMS5 | |
| KKTTTRWCHIVRDSD | 321 | Q9UMS5 | |
| IATKCQKWRHSQVTN | 281 | Q5VYX0 | |
| DVTWKQAKDIVQHCT | 611 | P10266 | |
| DVTWKQAKDIVQHCT | 611 | P63133 | |
| WEITKKTCAYTNHTV | 366 | P11216 | |
| DVTWKQAKDIVQHCT | 611 | Q9UQG0 | |
| KIEWNSRVVSTCHSL | 46 | Q96MV1 | |
| SKKHLQDVDTWKSRC | 531 | P98168 | |
| KSFNCNSSLIKHWRV | 401 | Q3KQV3 | |
| WTLKQAQLHCQASEK | 191 | Q5SQS7 | |
| TWKQAKDIVQHCTQC | 616 | Q9WJR5 | |
| LCKHCTTINIDSTWQ | 81 | Q70CQ2 | |
| HCVQTIASVARVKWR | 246 | Q96S15 | |
| CSKNVQRKQRHWEKI | 61 | Q6PF06 | |
| SRVEVWEKTSCSKQV | 126 | Q86XD8 | |
| RGCKQVTVTHWKIQT | 76 | O75123 | |
| ITKWPICTEQARSNH | 571 | Q6PJF5 | |
| QLCHISTTLAEKTWV | 2616 | Q9Y4A5 | |
| IALHWEINTQKISRC | 211 | P17097 | |
| FITVVNCKTWVKSHR | 26 | Q9NYW5 | |
| NCKTWVKSHRISSSD | 31 | Q9NYW5 |